{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:28:00Z","timestamp":1794623280374,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Obesity-associated insulin resistance (IR) is closely related to intramyocellular lipid accumulation in skeletal muscle. FAM3 metabolism regulating signaling molecule A (FAM3A) is expressed and secreted in almost all tissues. However, its biological roles and underlying mechanisms remain largely unknown. Here, we reported that abnormal lipid metabolism decreased the FAM3A level. To investigate the function of FAM3A, a transgenic mouse strain was generated, in which FAM3A protein was overexpressed systemically. Proteomic analyses revealed that proteins related to lipid metabolic processes, specifically fatty acid (FA) synthesis complex enzymes and adiponectin were upregulated in the skeletal muscles of the FAM3A-transgenic mice compared with those in the skeletal muscles of the wild-type control mice. Furthermore, a positive correlation between FAM3A and adiponectin levels was observed in patient plasma samples. FAM3A transgene or FAM3A injection in high-fat diet (HFD)-fed mice led to increased levels of muscular srebp1, fas, acc, and acly expression, De novo FA biosynthesis, and lipid accumulation compared with those in matched controls. However, FAM3A transgene or FAM3A injection suppressed IR and inflammation and promoted glucose consumption in HFD-fed mice. Moreover, these functions of FAM3A were attenuated by the inhibition of PPAR\u03b1. Notably, the inhibition of the insulin receptor abolished the linkage of FAM3A and PPAR\u03b1 as well as their downstream metabolic effects. Taken together, these findings suggest that increasing FAM3A expression in the body may represent a unique opportunity to avoid IR in individuals with obesity induced by high lipid levels.<\/jats:p>","DOI":"10.1038\/s41419-025-08298-1","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:26:57Z","timestamp":1765078017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["FAM3A drives uncoupling of muscle lipid accumulation and insulin resistance depending on insulin receptor"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1222-746X","authenticated-orcid":false,"given":"Dan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9627-828X","authenticated-orcid":false,"given":"Xiaohong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenghan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7976-7252","authenticated-orcid":false,"given":"Wenxuan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3053-6138","authenticated-orcid":false,"given":"Xiangyu","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0704-5469","authenticated-orcid":false,"given":"Yuehong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"key":"8298_CR1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/geno.2002.6816","volume":"80","author":"Y Zhu","year":"2002","unstructured":"Zhu Y, Xu G, Patel A, McLaughlin MM, Silverman C, Knecht KA, et al. Cloning, expression, and initial characterization of a novel cytokine-like gene family. Genomics. 2002;80:144\u201350.","journal-title":"Genomics"},{"key":"8298_CR2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.metabol.2017.12.001","volume":"81","author":"X Zhang","year":"2018","unstructured":"Zhang X, Yang W, Wang J, Meng Y, Guan Y, Yang J. FAM3 gene family: a promising therapeutical target for NAFLD and type 2 diabetes. Metabolism. 2018;81:71\u201382.","journal-title":"Metabolism"},{"key":"8298_CR3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/jgh.12033","volume":"28","author":"J Yang","year":"2013","unstructured":"Yang J, Guan Y. Family with sequence similarity 3 gene family and nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2013;28:105\u201311.","journal-title":"J Gastroenterol Hepatol"},{"key":"8298_CR4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1753-4887.2011.00457.x","volume":"70","author":"C Wang","year":"2012","unstructured":"Wang C, Burkhardt BR, Guan Y, Yang J. Role of pancreatic-derived factor in type 2 diabetes: evidence from pancreatic beta cells and liver. Nutr Rev. 2012;70:100\u20136.","journal-title":"Nutr Rev"},{"key":"8298_CR5","volume":"74","author":"X Li","year":"2024","unstructured":"Li X, Yuan F, Xiong Y, Tang Y, Li Z, Ai J, et al. FAM3A plays a key role in protecting against tubular cell pyroptosis and acute kidney injury. Redox Biol. 2024;74:103225.","journal-title":"Redox Biol"},{"key":"8298_CR6","volume":"139","author":"H Yan","year":"2023","unstructured":"Yan H, Meng Y, Li X, Xiang R, Hou S, Wang J, et al. FAM3A maintains metabolic homeostasis by interacting with F1-ATP synthase to regulate the activity and assembly of ATP synthase. Metabolism. 2023;139:155372.","journal-title":"Metabolism"},{"key":"8298_CR7","doi-asserted-by":"crossref","unstructured":"Wang D, Wei T, Cui X, Xia L, Jiang Y, Yin D, et al. Fam3a-mediated prohormone convertase switch in alpha-cells regulates pancreatic GLP-1 production in an Nr4a2-Foxa2-dependent manner. Metabolism. 2025;162, 156042.","DOI":"10.1016\/j.metabol.2024.156042"},{"key":"8298_CR8","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.26945","volume":"59","author":"C Wang","year":"2014","unstructured":"Wang C, Chi Y, Li J, Miao Y, Li S, Su W, et al. FAM3A activates PI3K p110alpha\/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis. Hepatology. 2014;59:1779\u201390.","journal-title":"Hepatology"},{"key":"8298_CR9","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09746-1","volume":"10","author":"D Sala","year":"2019","unstructured":"Sala D, Cunningham TJ, Stec MJ, Etxaniz U, Nicoletti C, Dall\u2019Agnese A, et al. The Stat3-Fam3a axis promotes muscle stem cell myogenic lineage progression by inducing mitochondrial respiration. Nat Commun. 2019;10:1796.","journal-title":"Nat Commun"},{"key":"8298_CR10","volume":"14","author":"C Lei","year":"2023","unstructured":"Lei C, Kan H, Xian X, Chen W, Xiang W, Song X, et al. FAM3A reshapes VSMC fate specification in abdominal aortic aneurysm by regulating KLF4 ubiquitination. Nat Commun. 2023;14:5360.","journal-title":"Nat Commun"},{"key":"8298_CR11","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.3390\/ijms24129818","volume":"24","author":"D Szukiewicz","year":"2023","unstructured":"Szukiewicz D. Molecular mechanisms for the vicious cycle between insulin resistance and the inflammatory response in obesity. Int J Mol Sci. 2023;24:9818.","journal-title":"Int J Mol Sci"},{"key":"8298_CR12","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/er.2018-00064","volume":"39","author":"N Bougarne","year":"2018","unstructured":"Bougarne N, Weyers B, Desmet SJ, Deckers J, Ray DW, Staels B, et al. Molecular actions of PPARalpha in lipid metabolism and inflammation. Endocrine Rev. 2018;39:760\u2013802.","journal-title":"Endocrine Rev"},{"key":"8298_CR13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2515\/therapie:2007051","volume":"62","author":"B Staels","year":"2007","unstructured":"Staels B. PPAR agonists and the metabolic syndrome. Therapie. 2007;62:319\u201326.","journal-title":"Therapie"},{"key":"8298_CR14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI27989","volume":"116","author":"P Lefebvre","year":"2006","unstructured":"Lefebvre P. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Investig. 2006;116:571\u201380.","journal-title":"J Clin Investig"},{"key":"8298_CR15","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature08945","volume":"464","author":"CE Hagberg","year":"2010","unstructured":"Hagberg CE, Falkevall A, Wang X, Larsson E, Huusko J, Nilsson I, et al. Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature. 2010;464:917\u201321.","journal-title":"Nature"},{"key":"8298_CR16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1152\/physrev.00024.2006","volume":"87","author":"DB Savage","year":"2007","unstructured":"Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev. 2007;87:507\u201320.","journal-title":"Physiol Rev"},{"key":"8298_CR17","first-page":"8","volume":"95","author":"KF Petersen","year":"2002","unstructured":"Petersen KF, Shulman GI. Cellular mechanism of insulin resistance in skeletal muscle. Journal R Soc Med. 2002;95:8\u201313.","journal-title":"Journal R Soc Med"},{"key":"8298_CR18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ebiom.2019.03.038","volume":"43","author":"W Xu","year":"2019","unstructured":"Xu W, Liang M, Zhang Y, Huang K, Wang C. Endothelial FAM3A positively regulates post-ischaemic angiogenesis. EBioMedicine. 2019;43:32\u201342.","journal-title":"EBioMedicine"},{"key":"8298_CR19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.tem.2024.10.006","volume":"36","author":"J Chen","year":"2025","unstructured":"Chen J, Markworth JF, Ferreira C, Zhang C, Kuang S. Lipid droplets as cell fate determinants in skeletal muscle. Trends Endocrinol Metab TEM. 2025;36:645\u201359.","journal-title":"Trends Endocrinol Metab TEM"},{"key":"8298_CR20","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/emmm.201100671","volume":"5","author":"N Krahmer","year":"2013","unstructured":"Krahmer N, Farese RV Jr., Walther TC. Balancing the fat: lipid droplets and human disease. EMBO Mol Med. 2013;5:973\u201383.","journal-title":"EMBO Mol Med"},{"key":"8298_CR21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-22962-x","volume":"8","author":"K Verboven","year":"2018","unstructured":"Verboven K, Wouters K, Gaens K, Hansen D, Bijnen M, Wetzels S, et al. Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans. Sci Rep. 2018;8:4677.","journal-title":"Sci Rep"},{"key":"8298_CR22","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.120.316101","volume":"126","author":"ME Pich\u00e9","year":"2020","unstructured":"Pich\u00e9 ME, Tchernof A, Despr\u00e9s JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 2020;126:1477\u20131500.","journal-title":"Circ Res"},{"key":"8298_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2017.05.013","volume":"122","author":"G Seravalle","year":"2017","unstructured":"Seravalle G, Grassi G. Obesity and hypertension. Pharmacol Res. 2017;122:1\u20137.","journal-title":"Pharmacol Res"},{"key":"8298_CR24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.peptides.2018.06.007","volume":"106","author":"GH Marques-Oliveira","year":"2018","unstructured":"Marques-Oliveira GH, Silva TM, Lima WG, Valadares HMS, Chaves VE. Insulin as a hormone regulator of the synthesis and release of leptin by white adipose tissue. Peptides. 2018;106:49\u201358.","journal-title":"Peptides"},{"key":"8298_CR25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0163-7827(03)00040-7","volume":"43","author":"AE Leonard","year":"2004","unstructured":"Leonard AE, Pereira SL, Sprecher H, Huang YS. Elongation of long-chain fatty acids. Prog Lipid Res. 2004;43:36\u201354.","journal-title":"Prog Lipid Res"},{"key":"8298_CR26","doi-asserted-by":"crossref","first-page":"29069","DOI":"10.1074\/jbc.M110.120386","volume":"285","author":"YM Kim","year":"2010","unstructured":"Kim YM, Shin HT, Seo YH, Byun HO, Yoon SH, Lee IK, et al. Sterol regulatory element-binding protein (SREBP)-1-mediated lipogenesis is involved in cell senescence. J Biol Chem. 2010;285:29069\u201377.","journal-title":"J Biol Chem"},{"key":"8298_CR27","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1172\/JCI118951","volume":"98","author":"H Shimano","year":"1996","unstructured":"Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Investig. 1996;98:1575\u201384.","journal-title":"J Clin Investig"},{"key":"8298_CR28","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13683","volume":"7","author":"M Angela","year":"2016","unstructured":"Angela M, Endo Y, Asou HK, Yamamoto T, Tumes DJ, Tokuyama H, et al. Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPARgamma directs early activation of T cells. Nat Commun. 2016;7:13683.","journal-title":"Nat Commun"},{"key":"8298_CR29","volume":"11","author":"CQ Hu","year":"2024","unstructured":"Hu CQ, Hou T, Xiang R, Li X, Li J, Wang TT, et al. PANX1-mediated ATP release confers FAM3A\u2019s suppression effects on hepatic gluconeogenesis and lipogenesis. Mil Med Res. 2024;11:41.","journal-title":"Mil Med Res"},{"key":"8298_CR30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"SH Lee","year":"2022","unstructured":"Lee SH, Park SY, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J. 2022;46:15\u201337.","journal-title":"Diabetes Metab J"},{"key":"8298_CR31","volume":"119","author":"MA Hill","year":"2021","unstructured":"Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metab Clin Exp. 2021;119:154766.","journal-title":"Metab Clin Exp"},{"key":"8298_CR32","doi-asserted-by":"crossref","unstructured":"Yazici D, Sezer H. Insulin resistance, obesity and lipotoxicity. Adv Exp Med Biol. 2017;960:277\u2013304.","DOI":"10.1007\/978-3-319-48382-5_12"},{"key":"8298_CR33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature13478","volume":"510","author":"RJ Perry","year":"2014","unstructured":"Perry RJ, Samuel VT, Petersen KF, Shulman GI. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature. 2014;510:84\u201391.","journal-title":"Nature"},{"key":"8298_CR34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cmet.2013.03.002","volume":"17","author":"M Liesa","year":"2013","unstructured":"Liesa M, Shirihai OS. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 2013;17:491\u2013506.","journal-title":"Cell Metab"},{"key":"8298_CR35","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s42255-019-0041-z","volume":"1","author":"LG Straub","year":"2019","unstructured":"Straub LG, Scherer PE. Metabolic Messengers: Adiponectin. Nature Metab. 2019;1:334\u20139.","journal-title":"Nature Metab"},{"key":"8298_CR36","doi-asserted-by":"crossref","unstructured":"Engin A. Adiponectin resistance in obesity: adiponectin leptin\/insulin interaction. Adv Exp Med Biol. 2024;1460:431\u201362.","DOI":"10.1007\/978-3-031-63657-8_15"},{"key":"8298_CR37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.12997\/jla.2025.14.1.40","volume":"14","author":"E Tam","year":"2025","unstructured":"Tam E, Ouimet M, Sweeney G. Cardioprotective effects of adiponectin-stimulated autophagy. J Lipid Atheroscler. 2025;14:40\u201353.","journal-title":"J Lipid Atheroscler"},{"key":"8298_CR38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.gene.2016.09.038","volume":"595","author":"T Kang","year":"2016","unstructured":"Kang T, Peng D, Bu G, Gu H, Zhang F, Zhang R, et al. Transcriptional regulation analysis of FAM3A gene and its effect on adipocyte differentiation. Gene. 2016;595:92\u201398.","journal-title":"Gene"},{"key":"8298_CR39","doi-asserted-by":"crossref","first-page":"45862","DOI":"10.18632\/oncotarget.17578","volume":"8","author":"Y Chi","year":"2017","unstructured":"Chi Y, Li J, Li N, Chen Z, Ma L, Peng W, et al. FAM3A enhances adipogenesis of 3T3-L1 preadipocytes via activation of ATP-P2 receptor-Akt signaling pathway. Oncotarget. 2017;8:45862\u201373.","journal-title":"Oncotarget"},{"key":"8298_CR40","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1016\/j.bbagen.2013.03.029","volume":"1830","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Jia S, Wang C, Chen Z, Chi Y, Li J, et al. FAM3A is a target gene of peroxisome proliferator-activated receptor gamma. Biochim Biophys Acta. 2013;1830:4160\u201370.","journal-title":"Biochim Biophys Acta"},{"key":"8298_CR41","doi-asserted-by":"crossref","first-page":"155912","DOI":"10.1016\/j.metabol.2024.155912","volume":"155","author":"D Ezhilarasan","year":"2024","unstructured":"Ezhilarasan D. Deciphering the molecular pathways of saroglitazar: A dual PPAR alpha\/gamma agonist for managing metabolic NAFLD. Metab Clin Exp. 2024;155:155912.","journal-title":"Metab Clin Exp"},{"key":"8298_CR42","doi-asserted-by":"crossref","first-page":"8969","DOI":"10.3390\/ijms22168969","volume":"22","author":"M Tahri-Joutey","year":"2021","unstructured":"Tahri-Joutey M, Andreoletti P, Surapureddi S, Nasser B, Cherkaoui-Malki M, Latruffe N. Mechanisms mediating the regulation of peroxisomal fatty acid beta-oxidation by PPARalpha. Int J Mol Sci. 2021;22:8969.","journal-title":"Int J Mol Sci"},{"key":"8298_CR43","doi-asserted-by":"crossref","first-page":"21466","DOI":"10.1074\/jbc.M110.209973","volume":"286","author":"A Fern\u00e1ndez-Alvarez","year":"2011","unstructured":"Fern\u00e1ndez-Alvarez A, Alvarez MS, Gonzalez R, Cucarella C, Muntan\u00e9 J, Casado M. Human SREBP1c expression in liver is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem. 2011;286:21466\u201377.","journal-title":"J Biol Chem"},{"key":"8298_CR44","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nm1044","volume":"10","author":"SH Koo","year":"2004","unstructured":"Koo SH, Satoh H, Herzig S, Lee CH, Hedrick S, Kulkarni R, et al. PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat Med. 2004;10:530\u20134.","journal-title":"Nat Med"},{"key":"8298_CR45","doi-asserted-by":"crossref","first-page":"34036","DOI":"10.1074\/jbc.M109.051052","volume":"284","author":"MH Oosterveer","year":"2009","unstructured":"Oosterveer MH, Grefhorst A, van Dijk TH, Havinga R, Staels B, Kuipers F, et al. Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice. J Biol Chem. 2009;284:34036\u201344.","journal-title":"J Biol Chem"},{"key":"8298_CR46","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-2275(20)31655-2","volume":"42","author":"DD Patel","year":"2001","unstructured":"Patel DD, Knight BL, Wiggins D, Humphreys SM, Gibbons GF. Disturbances in the normal regulation of SREBP-sensitive genes in PPAR alpha-deficient mice. J Lipid Res. 2001;42:328\u201337.","journal-title":"J Lipid Res"},{"key":"8298_CR47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.yjmcc.2014.05.011","volume":"74","author":"S Jia","year":"2014","unstructured":"Jia S, Chen Z, Li J, Chi Y, Wang J, Li S, et al. FAM3A promotes vascular smooth muscle cell proliferation and migration and exacerbates neointima formation in rat artery after balloon injury. J Mol Cell Cardiol. 2014;74:173\u201382.","journal-title":"J Mol Cell Cardiol"},{"key":"8298_CR48","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/CIRCRESAHA.119.315558","volume":"126","author":"R Xiang","year":"2020","unstructured":"Xiang R, Chen J, Li S, Yan H, Meng Y, Cai J, et al. VSMC-specific deletion of FAM3A attenuated Ang II-promoted hypertension and cardiovascular hypertrophy. Circ Res. 2020;126:1746\u201359.","journal-title":"Circ Res"},{"key":"8298_CR49","doi-asserted-by":"crossref","unstructured":"Saltiel AR. Insulin signaling in health and disease. J Clin Investig. 2021;131:e142241.","DOI":"10.1172\/JCI142241"},{"key":"8298_CR50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrm.2017.89","volume":"19","author":"RA Haeusler","year":"2018","unstructured":"Haeusler RA, McGraw TE, Accili D. Biochemical and cellular properties of insulin receptor signalling. Nat Rev Mol Cell Biol. 2018;19:31\u201344.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8298_CR51","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41580-025-00826-3","volume":"26","author":"E Choi","year":"2025","unstructured":"Choi E, Duan C, Bai X. Regulation and function of insulin and insulin-like growth factor receptor signalling. Nat Rev Mol Cell Biol. 2025;26:558\u201380.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8298_CR52","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cell.2012.01.034","volume":"148","author":"T Kadowaki","year":"2012","unstructured":"Kadowaki T, Ueki K, Yamauchi T, Kubota N. SnapShot: insulin signaling pathways. Cell. 2012;148:624\u2013624.e1 e621.","journal-title":"Cell"},{"key":"8298_CR53","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/biomedicines9020127","volume":"9","author":"V Castelli","year":"2021","unstructured":"Castelli V, Catanesi M, Alfonsetti M, Laezza C, Lombardi F, Cinque B, et al. PPARalpha-selective antagonist GW6471 inhibits cell growth in breast cancer stem cells inducing energy imbalance and metabolic stress. Biomedicines. 2021;9:127.","journal-title":"Biomedicines"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08298-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08298-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08298-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:22:49Z","timestamp":1769098969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08298-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8298"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08298-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"29 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were approved by the Ethics Review Board of Peking Union Medical College Hospital (Approval No. [XHDW-2023-083-2]; Beijing, China). The use of human specimens was approved by the Ethics Review Board of Peking Union Medical College Hospital (Beijing, China), and all the participants included in the study provided written informed consent for the use of their plasma samples.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"72"}}